Grant Gwinup, MD
In patients with erectile insufficiency, it is often difficult to find a definite cause for the problem when clinical vascular disease, neurologic deficiency, obvious psychological problems, and endocrine abnormalities, including diabetes, have been excluded. Such patients are usually categorized as suffering from non-specific erectile insufficiency. A major addition to the literature on treating erectile insufficiency was the finding that intercavernosal injection of vasoactive substances often produces a dramatic effect in patients with non-specific erectile insufficiency, as well as in those whose disease was suspected to have a more precise cause (1-2). The injection technique, however, is inconvenient and has produced
Gwinup G. Oral Phentolamine in Nonspecific Erectile Insufficiency. Ann Intern Med. ;109:162–163. doi: 10.7326/0003-4819-109-2-162
Download citation file:
Published: Ann Intern Med. 1988;109(2):162-163.
Endocrine and Metabolism.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use